Pharmaguideline represents a niche vendor with a narrowly scoped vulnerability footprint centered on its core product line. Treat this as a compact vendor profile rather than a broad trend line; live severity, exploitation, and exposure counts are shown alongside this summary.
The number and severity of CVEs published that impact products developed by Pharmaguideline over time
Signals from CVEs in this vendor scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2014-6721MEDIUM The Pharmaguideline (aka com.pharmaguideline) application 1.2.0 for Android does not verify X.509 certificates from SSL servers, which allows man-in-the-middle attackers to spoof s | Sep 26, 2014 | 5.4 | 21 | NO | NO |
Signals from CVEs in this vendor scope (1 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by Pharmaguideline.
Media articles that mention a CVE ID that affects a product developed by Pharmaguideline — matched by CVE ID, not by vendor name.